Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him Directly To Discuss Their Options A class action was filed against against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”), Bain Capital Investors, LLC (“Bain”) and Pfizer, Inc. (“Pfizer”) on behalf of investors that (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through Au ...

案件概述 - 罗森律师事务所提醒在2023年10月11日至2024年8月1日期间出售或处置Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) 普通股的个人或实体可能有权获得补偿 [1] - 该集体诉讼涉及Cerevel与AbbVie Inc的合并案中持有股票并在2024年1月8日记录日有权投票的股东 [1] - 还包括在2023年10月16日Bain Capital购买股票同时出售Cerevel股票的股东 [1] 诉讼细节 - 指控被告在2023年10月16日的二次股票发行和2024年1月18日的代理声明中作出虚假和/或误导性陈述 [5] - 二次股票发行由Cerevel的控股股东Bain Capital LP和Pfizer Inc策划 允许Bain以大幅折扣价格增持Cerevel股份 [5] - 发行51天后 Cerevel宣布AbbVie同意以每股45美元收购Cerevel 几乎是发行价的两倍 Bain因此获得超过1.2亿美元的意外之财 [5] 律所背景 - 罗森律师事务所在全球范围内代表投资者 专注于证券集体诉讼和股东衍生诉讼 [4] - 该律所曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 2017年被ISS证券集体诉讼服务评为证券集体诉讼和解数量第一 自2013年以来每年排名前四 [4] - 2019年为投资者争取超过4.38亿美元赔偿 2020年创始合伙人Laurence Rosen被Law360评为原告律师界泰斗 [4] 参与方式 - 加入集体诉讼需在2025年6月3日前向法院提出申请 [3] - 主要原告是代表其他集体成员指导诉讼的代表方 [3] - 可通过网站或电话联系Phillip Kim律师获取案件信息 [3][6]

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”); (2) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc.; and/or (3) sold shares of Cer ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 27, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE) investors of a class action representing investors that bought securities between October 11, 2023 through August 1, 2024, inclusive (the "Class Period"). Cerevel investors have until June 3, 2025. to file a lead plaintiff motion. Investors are encouraged to contact ...

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”); (2) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc.; and/or (3) sold shares of Cer ...

NEW YORK, May 25, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds all persons or entities that: (1) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) during the period from October 11, 2023 through August 1, 2024, inclusive (the "Class Period"); (2) held shares of Cerevel as of the January 8, 2024 record date and were entitled to vote on the merger of Cerevel and AbbVie Inc.; and/or (3) sold shares of Cerevel ...

To join the Cerevel class action, go to https://rosenlegal.com/submit-form/?case_id=37997 mailto:or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to ...

LOS ANGELES, May 19, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company") (NASDAQ: CERE) investors of a class action representing investors that bought securities between October 11, 2023 through August 1, 2024, inclusive (the "Class Period"). Cerevel investors have until June 3, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discu ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Cerevel To Contact Him Directly To Discuss Their Options A class action was filed against against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”), Bain Capital Investors, LLC (“Bain”) and Pfizer, Inc. (“Pfizer”) on behalf of investors that (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through Au ...

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class ...